Experiment summary for ENCSR701EUC
doi:10.17989/ENCSR701EUC
Summary
- Status
- released
- Assay
- Mint-ChIP-seq
- Target
- H3K4me1
- Biosample summary
- Homo sapiens activated naive CD8-positive, alpha-beta T cell male adult (30 years) treated with anti-CD3 and anti-CD28 coated beads for 7 days, 10 ng/mL Interleukin-2 for 5 days
- Biosample Type
- primary cell
- Replication type
- unreplicated
- Description
- H3K4me1 Mint-ChIP-seq on activated CD8-positive, naive alpha-beta T cell male adult (30 years) treated with anti-CD3 and anti-CD28 coated beads , 10 ng/mL Interleukin-2
- Treatments
- anti-CD3 and anti-CD28 coated beads for 7 days, 10 ng/mL Interleukin-2 (UniProtKB:P60568) for 5 days
- Nucleic acid type
- DNA
- Platform
- Illumina NextSeq 500
- Controls
Attribution
ENCODE4 project
- Lab
- Bradley Bernstein, Broad
- Award
- UM1HG009390 (Bradley Bernstein, Broad)
- Project
- ENCODE
- External resources
- Aliases
- bradley-bernstein:Project Element 6570
- Date released
- June 24, 2021
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
|---|---|---|---|---|---|
| 1 | 1 | Homo sapiens male adult (30 years) activated naive CD8-positive, alpha-beta T primary cell treated with anti-CD3 and anti-CD28 coated beads for 7 days, 10 ng/mL Interleukin-2 for 5 days | ENCBS715FVA | ENCAB845ARK | ENCLB477EAN |
| 1 | 2 | Homo sapiens male adult (30 years) activated naive CD8-positive, alpha-beta T primary cell treated with anti-CD3 and anti-CD28 coated beads for 7 days, 10 ng/mL Interleukin-2 for 5 days | ENCBS715FVA | ENCAB845ARK | ENCLB107QSK |